April 26, 2017

5 Qualities to Consider When Selecting Clinical Pharmacology Units for Early Drug Development

IndiaProduction

IndiaProduction

Recommended Reports

Somatostatin Receptor Type 5 (SSTR5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

5-Hydroxytryptamine Receptor (Serotonin Receptor or 5 HT Receptor or HTR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Integrin Beta 5 (ITGB5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Arachidonate 5 Lipoxygenase (5 Lipoxygenase or Leukotriene A4 Synthase or ALOX5 or EC 1.13.11.34) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Prostatic Acid Phosphatase (5 Nucleotidase or Ecto 5 Nucleotidase or Thiamine Monophosphatase or ACPP or EC 3.1.3.2 or EC 3.1.3.5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

View All

More

Medical Technology UK 2023

International congress on pediatrics neonatal and nursing care, Prague

Outsourcing in Clinical Trials: Medical Devices USA 2023

Outsourcing in Clinical Trials West Coast (& device stream) 2023